# Young‐A Heo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/young-a-heo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,675 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 24 |
| i10-index | 35 |
| Last Known Institution | Bayer (New Zealand) |
| OpenAlex ID | https://openalex.org/A5017316657 |
| Works | 73 |

## Researcher papers

- [A Pharmacokinetic Standard for Babies and Adults](https://scholariq.org/papers/a-pharmacokinetic-standard-for-babies-and-adults/)
- [Golodirsen: First Approval](https://scholariq.org/papers/golodirsen-first-approval/)
- [Baloxavir: First Global Approval](https://scholariq.org/papers/baloxavir-first-global-approval/)
- [Efgartigimod: First Approval](https://scholariq.org/papers/efgartigimod-first-approval/)
- [Pegaspargase: A Review in Acute Lymphoblastic Leukaemia](https://scholariq.org/papers/pegaspargase-a-review-in-acute-lymphoblastic-leukaemia/)
- [Andexanet Alfa: First Global Approval](https://scholariq.org/papers/andexanet-alfa-first-global-approval/)
- [Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections](https://scholariq.org/papers/imipenem-cilastatin-relebactam-a-review-in-gram-negative-bacterial-infections/)
- [Mirvetuximab Soravtansine: First Approval](https://scholariq.org/papers/mirvetuximab-soravtansine-first-approval/)
- [Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients](https://scholariq.org/papers/population-pharmacokinetics-and-pharmacodynamics-of-linezolid-induced/)
- [Etranacogene Dezaparvovec: First Approval](https://scholariq.org/papers/etranacogene-dezaparvovec-first-approval/)
- [Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav®) in Sleep Disorders: A Profile of Its Use](https://scholariq.org/papers/calcium-magnesium-potassium-and-sodium-oxybates-xywav-in-sleep-disorders-a/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)
- [Chronic Obstructive Pulmonary Disease (COPD) Research](https://scholariq.org/topics/chronic-obstructive-pulmonary-disease-copd-research/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Bayer (New Zealand)](https://scholariq.org/institutions/bayer-new-zealand/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.